Alacrita Life Science Consulting Alacrita Life Science Consulting
  • Our Services
    • Product Development
      • Research & IP Evaluation
      • Preclinical Strategy & Execution
      • Clinical Development
      • Regulatory Affairs
      • CMC Consulting
      • Interim Chief Medical Officer
    • Strategy & Commercialization
      • Opportunity Mapping
      • Business Plans & Fundraising Support
      • New Product Planning
      • Launch Planning
    • Business Development
      • Due Diligence
      • Valuations
      • In-Licensing & Asset Scouting
      • Out-Licensing, Partnering & Deal-making
    • Expert Witness Services
    • By Client Type
      • Biotech
      • Virtual & Semi-Virtual Biotechs
      • Pharmaceutical Companies
      • Investors
      • Tech Transfer Offices
      • Animal Health Companies
    • By Product Modality
      • Antibodies, ADCs
      • Cell Therapies
      • Drug Discovery Platforms
      • Gene Therapies
      • Microbiome Drugs
      • Peptides & Proteins
      • Radiopharmaceuticls
      • Small Molecules
      • Other Product Modalities
    • By Disease Area
      • CNS
      • Digestive & GI
      • Endocrine & Metabolic
      • Fibrosis
      • Hematology
      • Immunology
      • Oncology
      • Respiratory
      • Other Disease Areas
  • Core Team
    • Alastair Southwell
    • Anthony Walker
    • Saadia Anastasiou
    • Michael Lombardo
    • Lucas Rodriguez
    • Mark Philip
    • Gary Mansfield
    • Christine McCarthy
    • Stuart Hendry
    • Simon Turner
    • Pierre Dodion
  • Consulting Network
  • Resources
    • Case Studies
    • Blog
    • News
    • Whitepapers
  • Careers
  • Contact

News

  • news and resources
  • News

Cort

Recent Posts

European Drug Development: A Masterclass

Join Alacrita at the CIC in Kendall Square on January 29th, for an educational session on European drug development and commercialization. You will learn about valuable insight into most challenging...
Learn More

Meet Alacrita at JPM

The Alacrita team will be attending JPM this year in San Francisco. This is always one of the industry's premier annual gatherings. We look forward to seeing many of our partners and colleagues...
Learn More

Alacrita Appoints Peter Traber to Lead Consulting on Anti-fibrotic Drug Development

Alacrita is pleased to announce the appointment of Peter G. Traber, MD, as Partner in its Waltham, MA office. Peter is a distinguished scientist and gastroenterologist/hepatologist with over 30 years...
Learn More
1

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

  • Strategy and Commercialization Learn more
  • Product Development Learn more
  • Business Development Learn more

© 2009-25 Alacrita Holdings Limited  |   Pharma & Biotech Consulting

  • Privacy Notice

Alacrita Consulting 
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608


One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.

Alacrita Life Science Consulting Alacrita Life Science Consulting